{"symbol":"PFE","fiscalQuarter":"Q2-2022","reportDate":"2022-07-28","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q2-2022","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 2.37%","keyNumbers":[{"metric":"EPS","actual":"$2.04","expected":"N/A","surprise":"+16.44%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","While we did not provide updated guidance, we remain focused on our long-term strategies."],"summary":"Management expressed satisfaction with the earnings per share results, highlighting their commitment to long-term goals despite not offering new guidance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 2.37%, likely due to a lack of updated guidance and broader market conditions. Investors may be cautious as the company navigates future uncertainties without clear direction.","metaDescription":"Pfizer Inc (PFE) Q2 2022 earnings: EPS beat expectations. Stock down 2.37%. Full breakdown."}}